Gene expression patterns that predict sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer cell lines and human lung tumors

BACKGROUND: Increased focus surrounds identifying patients with advanced non-small cell lung cancer (NSCLC) who will benefit from treatment with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI). EGFR mutation, gene copy number, coexpression of ErbB proteins and ligands, and e...

Descripción completa

Detalles Bibliográficos
Autores principales: Balko, Justin M, Potti, Anil, Saunders, Christopher, Stromberg, Arnold, Haura, Eric B, Black, Esther P
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1660550/
https://www.ncbi.nlm.nih.gov/pubmed/17096850
http://dx.doi.org/10.1186/1471-2164-7-289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1660550/
https://www.ncbi.nlm.nih.gov/pubmed/17096850
http://dx.doi.org/10.1186/1471-2164-7-289

Ejemplares similares